The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

NCT00152178 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

680

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: UFT (uracil, tegafur) and tamoxifen
DRUG: CMF(cyclophosphamide, methotrexate, fluorouracil) and tamoxifen

Sponsor

Taiho Pharmaceutical Co., Ltd.